Latest News
-

Turning skin cells into brain cells: a Huntington's disease research breakthrough?
Scientists can now change human skin cells into working neurons, like the ones that are most affected in HD.
-

Huntington's disease clinical trial announcement: huntingtin-lowering drug to enter Phase I trial in 2015
A clinical trial for an exciting therapy against HD is planned for 2015. The first step is to make sure it is safe.
-

Largest creatine clinical trial for Huntington's disease halted after 'futility' analysis
CREST-E, a trial of the supplement creatine, has been stopped after an early analysis found it couldn't show benefit
-

Should we worry about a huntingtin invasion?
Cool lab experiments show the huntington's disease protein jumping between cells. Does this matter for HD patients?
-

EuroBuzz 2014 Video, day one
Video of our first live session at the European Huntington's Disease Network Meeting.
-

EuroBuzz 2014 Video, day two
Video of our second live session at the European Huntington's Disease Network Meeting.
-

Melatonin alterations in Huntington's disease help explain trouble with sleep
Study shows HD patients have decreased levels of melatonin, which may explain why so many suffer from sleep problems
-

EuroBuzz 2014: day three
Our third and final report on the 2014 European Huntington's Disease Network meeting in Barcelona
-

EuroBuzz 2014: day two
HDBuzz reports on the second day of science at the European HD Network meeting in Barcelona
-

EuroBuzz 2014: day one
Highlights from the opening day of the 2014 European Huntington's Disease network in Barcelona, Spain
HDBuzz Trial Tracker
Progress update for NCT06585449 – A Study to Evaluate ALN-HTT02
Additional insights from Phase 2 study results and update on plans for Phase 3 trial for votoplam
Updates from the ongoing placebo-controlled Phase 2/3 FALCON-HD trial
Previously featured
-
A Window into the Eyes: Using Ocular Biomarkers to Track Progression in Huntington’s Disease
-
A Fault In The Supercomputer
-
Split Between Two Worlds: The Psychological Challenges for People at Risk of Huntington’s Disease
-
Putting it in print: oral drug branaplam lowered huntingtin, but safety concerns halted development
-
A hitch in the stitch reveals why DNA sequence patterns matter in Huntington’s disease
Follow HDBuzz
Sign up to our monthly email summary by entering your email address on our mailing list page.
Suggest an article
Is there something you want us to write about? Tell us about it here. We consider all suggestions but can’t promise to write content about any particular suggestion.
